<?xml version="1.0" encoding="UTF-8"?>
<p>Secondary endpoints assessed for each cycle included the following: (1) time to ANC recovery, defined as the time from chemotherapy administration until an increase in ANC to ≥2.0 × 10
 <sup>9</sup>/L after the expected nadir (date of ANC recovery – date of chemotherapy +1); (2) depth of ANC nadir, defined as the lowest ANC value; (3) time to ANC nadir, defined as the time from chemotherapy administration until the occurrence of the ANC nadir (date of ANC nadir – date of chemotherapy +1); (4) incidence of febrile neutropenia, defined as a temperature of &gt;38.2°C occurring within 1 day of an ANC &lt;0.5 × 10
 <sup>9</sup>/L, and/or a reported AE of febrile neutropenia; and (5) hospitalizations for any reason, including febrile neutropenia.
</p>
